MK-6050
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 16, 2026
A clinical trial of MK-6050 in healthy participants (MK-6050-002)
(clinicaltrialsregister.eu)
- P1 | N=52 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
New P1 trial • Dermatology • Hidradenitis Suppurativa • Immunology
1 to 1
Of
1
Go to page
1